期刊文献+

黄芪甲苷纳米结构脂质载体冻干粉的制备及其初步质量评价 被引量:6

Preparation and preliminary characterization of lyophilized astragaloside IV-loaded nanostructured lipid carriers
原文传递
导出
摘要 目的制备黄芪甲苷纳米结构脂质载体(AST-NLC),初步研究其冻干工艺,并考察其理化性质。方法采用薄膜-超声分散法制备AST-NLC;选用不同冻干保护剂制备AST-NLC冻干粉末,以外观、色泽、再分散性、粒径和PDI为综合指标,优选保护剂的种类和浓度,拟定冻干工艺;考察AST-NLC的形态和冻干前后的粒径分布、Zeta电位、包封率及载药量。结果以10%的蔗糖作为冻干保护剂、-40℃超低温冰箱中预冻4 h后,迅速放入冷冻干燥机中冷冻干燥24 h,所得冻干粉末的外观、色泽、再分散性均较好;AST-NLC在透射电镜下呈球形;冻干前(后)的平均粒径为104.3±1.25 nm(144.1±17.08nm),PDI为0.118±0.033(0.132±0.055),Zeta电位为-7.00±0.35 mV(-11.2±0.9 mV),包封率为94.37%±0.39%(96.60%±0.45%),载药量为2.80%±0.02%(2.60%±0.05%)。结论所用AST-NLC的制备工艺简便,制得的AST-NLC包封率较高;采用优化后的冻干工艺可得到令人满意的AST-NLC冻干粉末。 OBJECTIVE To prepare and characterize the lyophilized Astragaloside IV-loaded nanostructured lipid carriers(AST-NLC).METHODS AST-NLC was prepared by film-ultrasound dispersion technique.The lyophilized AST-NLC were prepared using different supporting agent.The type and concentration of the supporting agents were optimized by the shape,color,redispersion,size and PDI of the lyophilized AST-NLC.The characteristics of AST-NLC,including shape,size,PDI,Zeta potential,entrapment efficiency(EE%) and drug loading(DL%),before and after freeze-drying were investigated.RESULTS Satisfied lyophilized AST-NLC could be prepared using 10% sucrose as the supporting agent.The freeze-drying process was as follow:pre-cooled at 40 ℃ for 4 h,freeze-drying for 24 h.AST-NLC presented a spherical shape under transmission elecctron microscopy(TEM).The characteristics before freeze-drying were as follows:average diameter was 104.3±1.25 nm,PDI was 0.118±0.033,Zeta potential was-7.00±0.35 mV,entrapment efficiency and drug loading were 94.37%±0.39% and 2.80%±0.02%,respectively.After freeze drying,the average diameter was 144.1±17.08 nm,PDI was 0.132±0.055,Zeta potential was-11.2±0.9 mV,the entrapment efficiency and drug loading were 96.60%±0.45% and 2.60%±0.05%,respectively.CONCLUSION The preparation of AST-NLC is convenient and the produced AST-NLC has a high entrapment efficiency.Satisfied lyophilized AST-NLC can be prepared using 10% sucrose as the supporting agent.
作者 陈佳 龚涛
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第6期530-533,共4页 West China Journal of Pharmaceutical Sciences
关键词 黄芪甲苷 纳米结构脂质载体 包封率 冷冻干燥 Astragaloside IV Nanostructured lipid carriers Entrapment efficiency Freeze-drying
  • 相关文献

参考文献8

二级参考文献74

共引文献70

同被引文献94

  • 1高志红,左亚奇,李鹏涛,张辉,李海峰,张晓丽.黄芪甲苷Ⅳ诱导小鼠骨髓间充质干细胞向神经细胞分化机制的研究[J].中药材,2019,42(7):1640-1645. 被引量:8
  • 2李勇,曲韵智,李津明,高建玲.纳米结构脂质载体的研究进展[J].黑龙江医药,2009,22(6):781-784. 被引量:7
  • 3李汶霞,孙圣刚,袁慧,王海涛,张颜波,孙保亮.黄芪多糖对星形胶质细胞培养液中自由基系统损伤保护作用的时间依赖性[J].中国临床康复,2006,10(11):59-61. 被引量:8
  • 4Mailer R H, Hildebrand G E. Pharmazeutische Technologie: Modeme Arzneiformen [ M ]. Stuttgart : Wissenschaftliche Ver- lagsgesellschaft, 2003: 246-253.
  • 5Muller R H, Mader K, Gohla S H. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art[J]. Eur J Pharm Biopharm, 2000, 50( 1 ) : 161-177.
  • 6Muller R H, Radtke M, Wissing S A. Nanostructured lipid ma- trices for improved microencapsu-lation of drugs [ J ]. lnt J Pharm, 2002, 242(1-2) : 121-128.
  • 7Pathak P, Nagarsenker M. Formulation and evaluation of lido- caine lipid nanosystems for dermal delivery [ J ]. AAPS Pharm Sci Tech, 2009, 10(3): 985-992.
  • 8Sanad R A, Abdelmalak N S, Elbayoomy T S, et al. Formula- tion of a novel oxybenzone-loaded nanostmctured lipid carriers (NLCs) [J]. AAPS Pharm Sci Tech, 2010, 11 (4): 1684-1594.
  • 9Mosharraf M, Taylor K M, Craig D Q. Effect of calcium ions on the surface charge and aggregation of phosphadylcholine lipo- somesIJl. JDrug Target, 1995, 2(6): 541.
  • 10进藤大辅,及川哲夫.材料评价的分析电子显微方法[M].刘安生译.北京:冶金工业出版社,2011:1-10.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部